4.5 Review

Prevalence of depression and anxiety among myasthenia gravis (MG) patients: A systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Psychiatry

Validity of the Hospital Anxiety and Depression Scale (HADS) in primary care patients in Colombia

Carlos Arturo Cassiani-Miranda et al.

Summary: This study assessed the validity of the Hospital Anxiety and Depression Scale (HADS) for screening depression and anxiety in primary care patients in Colombia. The results showed that HADS is a valid and reliable tool for screening depression and anxiety in the primary healthcare setting in Colombia.

GENERAL HOSPITAL PSYCHIATRY (2022)

Article Public, Environmental & Occupational Health

Post-traumatic stress disorder symptoms after respiratory insufficiency in patients with myasthenia gravis

Chanchan Liu et al.

Summary: PTSD is common in patients with MG after respiratory insufficiency, with anxiety and depression being associated with a higher likelihood of screening positive for PTSD.

PSYCHOLOGY HEALTH & MEDICINE (2021)

Review Clinical Neurology

Prevalence of depreesion among amyotrophic lateral sclerosis(ALS) patients: A systematic review and meta-analysis

Mohammad Eghbal Heidari et al.

Summary: ALS patients have a high prevalence of depression, which significantly affects their quality of life and mobility. The severity of depression varies among patients, with different assessment tools showing varying prevalence rates. Identifying and addressing depression in ALS patients is crucial in clinical practice to improve overall outcomes.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Review Clinical Neurology

A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis

Victoria Leopardi et al.

Summary: The study aimed to investigate the association of infectious agents with the onset of myasthenia gravis (MG), with a hypothesis that microbes play a pathogenic role in initiating MG. Among 827 papers screened, 42 met the inclusion and exclusion criteria, and the infected patients with Epstein-Barr virus, human papillomavirus, and poliovirus showed the highest integrated metric of evidence (IME) values. The overall lack of evidence for a causal link between microbes and MG highlights the need for further mechanistic studies in this area.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Chronic stress, depression and personality type in patients with myasthenia gravis

A. Bogdan et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Article Oncology

Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients

Maria Antonietta Annunziata et al.

SUPPORTIVE CARE IN CANCER (2020)

Review Clinical Neurology

Management of Juvenile Myasthenia Gravis

Karen O'Connell et al.

FRONTIERS IN NEUROLOGY (2020)

Article Environmental Sciences

Validity and Reliability of the Beck Anxiety Inventory (BAI) for Family Caregivers of Children with Cancer

Filiberto Toledano-Toledano et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Ophthalmology

Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study

Tina M. Hendricks et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)

Meeting Abstract Clinical Neurology

Prevalence of depression among sudanese patients with myasthenia gravis

A. Siddig et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)

Article Clinical Neurology

Clinical characteristics of patients with myasthenia gravis accompanied by psychiatric disorders

Asami Yamamoto et al.

NEUROLOGY AND CLINICAL NEUROSCIENCE (2019)

Editorial Material Clinical Neurology

Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis

Nayara Felicidade Tomaz Braz et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2018)

Review Clinical Neurology

Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis

Rosa E. Boeschoten et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Psychiatry

Reliability and Validity of the Beck Depression Inventory-II among Korean Adolescents

Eun-Ho Lee et al.

PSYCHIATRY INVESTIGATION (2017)

Article Psychiatry

Neuropsychiatric symptoms in patients with thymoma-associated and non-thymoma myasthenia gravis

Carla Freeman et al.

South African Journal of Psychiatry (2017)

Article Neurosciences

Quality of life in 188 patients with myasthenia gravis in China

Yongxiang Yang et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2016)

Article Clinical Neurology

Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis

R. Sacco et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

Qing-Fei Zhao et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

Article Behavioral Sciences

Fatigue in myasthenia gravis: risk factors and impact on quality of life

Sarah Hoffmann et al.

BRAIN AND BEHAVIOR (2016)

Article Psychology, Applied

Psychometric Meta-Analysis of the English Version of the Beck Anxiety Inventory

Gerta Bardhoshi et al.

JOURNAL OF COUNSELING AND DEVELOPMENT (2016)

Article Clinical Neurology

Clinical features and impact of myasthenia gravis disease in Australian patients

Stefan Blum et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2015)

Article Neurosciences

Preoperative High-Dose Steroid Has Long-Term Beneficial Effects for Myasthenia Gravis

Syuichi Tetsuka et al.

NEUROLOGY RESEARCH INTERNATIONAL (2013)

Article Rheumatology

Measures of Depression and Depressive Symptoms

Karen L. Smarr et al.

ARTHRITIS CARE & RESEARCH (2011)

Article Rheumatology

Measures of Anxiety

Laura J. Julian

ARTHRITIS CARE & RESEARCH (2011)

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)